化合物CP21R7 T3684

Product Introduction
Bioactivity


英文名: CP21R7

描述: CP21R7 (CP21) 是一种 GSK-3β抑制剂，其 IC50=1.8 nM。它也是一种 PKCα抑制剂，其 IC50=1900 nM。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : 1 mg/mL (3.15 mM)
DMSO : 59 mg/mL (185.9 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)


关键字: CP 21 | Glycogen synthase kinase 3 | Inhibitor | CP21R7 | GSK-3 | CP-21 | Glycogen synthase kinase-3 | CP-21R7 | inhibit

相关产品: Citric acid trilithium salt tetrahydrate | PIMPC | BIO-acetoxime | GSK-3β inhibitor 14 | PHA-767491 | VP3.15 dihydrobromide | TBB | ALSTERPAULLONE | GSK-3β inhibitor 2 | GSK3-IN-3

相关库: Anti-Neurodegenerative Disease Compound Library | Anti-Prostate Cancer Compound Library | Wnt/Hedgehog/Notch Compound Library | Neuronal Differentiation Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Obesity Compound Library | Anti-Colorectal Cancer Compound Library | TGF-beta/Smad Compound Library | Reprogramming Compound Library

化合物CP21R7 T3684信息由TargetMol中国为您提供，如您想了解更多关于化合物CP21R7 T3684报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途